GeoVax Labs Valuation
| GOVX Stock | USD 2.95 0.25 9.26% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. GeoVax Labs retains a regular Real Value of $3.64 per share. The prevalent price of the firm is $2.95. Our model calculates the value of GeoVax Labs from evaluating the firm fundamentals such as Return On Asset of -1.34, shares outstanding of 9.44 M, and Return On Equity of -3.62 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting GeoVax Labs' valuation include:
Price Book 2.8961 | Enterprise Value 23.2 M | Enterprise Value Ebitda 0.1027 | Price Sales 84.7334 | Forward PE 10.627 |
Undervalued
Today
Please note that GeoVax Labs' price fluctuation is dangerous at this time. Calculation of the real value of GeoVax Labs is based on 3 months time horizon. Increasing GeoVax Labs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since GeoVax Labs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GeoVax Stock. However, GeoVax Labs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.95 | Real 3.64 | Target 6.0 | Hype 2.97 | Naive 2.9 |
The intrinsic value of GeoVax Labs' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence GeoVax Labs' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of GeoVax Labs helps investors to forecast how GeoVax stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GeoVax Labs more accurately as focusing exclusively on GeoVax Labs' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use GeoVax Labs' intrinsic value based on its ongoing forecasts of GeoVax Labs' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against GeoVax Labs' closest peers.
GeoVax Labs Cash |
|
GeoVax Valuation Trend
Analysing the historical paterns of GeoVax Labs' enterprise value and its market capitalization is a good way to estimate and gauge the value of GeoVax Labs over time and is usually enough for investors to make rational market timing decisions.
GeoVax Labs Total Value Analysis
GeoVax Labs is currently anticipated to have valuation of 23.21 M with market capitalization of 25.48 M, debt of 3.52 M, and cash on hands of 30.9 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the GeoVax Labs fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
23.21 M | 25.48 M | 3.52 M | 30.9 M |
GeoVax Labs Asset Utilization
One of the ways to look at asset utilization of GeoVax is to check how much profit was generated for every dollar of assets it reports. GeoVax Labs retains a negative application of resources of -1.34 (percent), losing $0.0134 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of GeoVax Labs shows how discouraging it operates for each dollar spent on its resources.GeoVax Labs Ownership Allocation
The market capitalization of GeoVax Labs is $25.48 Million. Roughly 88.66 (percent) of GeoVax Labs outstanding shares are held by general public with 0.52 % owned by insiders and only 10.82 pct. by outside corporations. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.GeoVax Labs Profitability Analysis
Net Loss for the year was (25.97 M) with profit before overhead, payroll, taxes, and interest of 81.53 K.About GeoVax Labs Valuation
Our relative valuation model uses a comparative analysis of GeoVax Labs. We calculate exposure to GeoVax Labs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GeoVax Labs's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -20.7 M | -19.7 M | |
| Pretax Profit Margin | (155.80) | (148.01) | |
| Operating Profit Margin | (199.18) | (189.22) | |
| Net Loss | (198.97) | (189.02) | |
| Gross Profit Margin | 0.35 | 0.37 |
GeoVax Labs Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 2.5 M | |
| Forward Price Earnings | 10.627 |
GeoVax Labs Current Valuation Indicators
Valuation refers to the process of determining the present value of GeoVax Labs and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value GeoVax we look at many different elements of the entity such as GeoVax's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as GeoVax Labs, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use GeoVax Labs' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes GeoVax Labs' worth.Additional Tools for GeoVax Stock Analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.